These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30836637)

  • 21. Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults.
    Cantero I; Elorz M; Abete I; Marin BA; Herrero JI; Monreal JI; Benito A; Quiroga J; Martínez A; Huarte MP; Uriz-Otano JI; Tur JA; Kearney J; Martinez JA; Zulet MA
    Int J Med Sci; 2019; 16(1):75-83. PubMed ID: 30662331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults.
    Kühn T; Nonnenmacher T; Sookthai D; Schübel R; Quintana Pacheco DA; von Stackelberg O; Graf ME; Johnson T; Schlett CL; Kirsten R; Ulrich CM; Kaaks R; Kauczor HU; Nattenmüller J
    BMC Gastroenterol; 2018 Jul; 18(1):113. PubMed ID: 30005625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.
    Goss AM; Dowla S; Pendergrass M; Ashraf A; Bolding M; Morrison S; Amerson A; Soleymani T; Gower B
    Pediatr Obes; 2020 Jul; 15(7):e12630. PubMed ID: 32128995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver.
    Al-Jiffri O; Al-Sharif FM; Abd El-Kader SM; Ashmawy EM
    Afr Health Sci; 2013 Sep; 13(3):667-72. PubMed ID: 24250305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diet-induced weight loss decreases adipose tissue oxygen tension with parallel changes in adipose tissue phenotype and insulin sensitivity in overweight humans.
    Vink RG; Roumans NJ; Čajlaković M; Cleutjens JPM; Boekschoten MV; Fazelzadeh P; Vogel MAA; Blaak EE; Mariman EC; van Baak MA; Goossens GH
    Int J Obes (Lond); 2017 May; 41(5):722-728. PubMed ID: 28179648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of pericardial fat with liver fat and insulin sensitivity after diet-induced weight loss in overweight women.
    Bosy-Westphal A; Kossel E; Goele K; Blöcker T; Lagerpusch M; Later W; Heller M; Glüer CC; Müller MJ
    Obesity (Silver Spring); 2010 Nov; 18(11):2111-7. PubMed ID: 20224561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.
    Ryan MC; Abbasi F; Lamendola C; Carter S; McLaughlin TL
    Diabetes Care; 2007 May; 30(5):1075-80. PubMed ID: 17351275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.
    Eslamparast T; Tandon P; Raman M
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
    Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
    Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restricted feeding for 9h in the active period partially abrogates the detrimental metabolic effects of a Western diet with liquid sugar consumption in mice.
    Woodie LN; Luo Y; Wayne MJ; Graff EC; Ahmed B; O'Neill AM; Greene MW
    Metabolism; 2018 May; 82():1-13. PubMed ID: 29253490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Branched-chain amino acid catabolism rather than amino acids plasma concentrations is associated with diet-induced changes in insulin resistance in overweight to obese individuals.
    Haufe S; Engeli S; Kaminski J; Witt H; Rein D; Kamlage B; Utz W; Fuhrmann JC; Haas V; Mähler A; Schulz-Menger J; Luft FC; Boschmann M; Jordan J
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):858-864. PubMed ID: 28958691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk.
    Bozzetto L; Annuzzi G; Ragucci M; Di Donato O; Della Pepa G; Della Corte G; Griffo E; Anniballi G; Giacco A; Mancini M; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):623-629. PubMed ID: 27134062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss.
    Haufe S; Haas V; Utz W; Birkenfeld AL; Jeran S; Böhnke J; Mähler A; Luft FC; Schulz-Menger J; Boschmann M; Jordan J; Engeli S
    Diabetes Care; 2013 Nov; 36(11):3786-92. PubMed ID: 23963894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Pataky Z; Genton L; Spahr L; Lazarevic V; Terraz S; Gaïa N; Rubbia-Brandt L; Golay A; Schrenzel J; Pichard C
    Dig Dis Sci; 2016 Sep; 61(9):2721-31. PubMed ID: 27142672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.
    Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A
    Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.